
by Xineplus
XineDiscover is Xineplus's closed-loop AI drug discovery platform. It generates drug-like molecules, screens them against protein targets, predicts ADMET properties and optimizes lead candidates.
Web appContact for pricing
Step 1: Request a demo from Xineplus.
Step 2: Define your objectives as design criteria, constraints and decision thresholds.
Step 3: Run the generate, simulate, optimize loop across many cycles.
Step 4: Review the ranked candidates with their uncertainty and explanations.
Step 5: Move the strongest candidates into synthesis or assay testing.
The platform generates candidates, simulates their properties, optimizes with multi-objective selection, and sends insights back to the generator for the next cycle.
An evidence package with context, including confidence, provenance and validation guidance, rather than a bare score.
XineDiscover covers drugs. Xineplus also lists separate platforms for materials, proteins and genomics.
The site invites you to request a demo, and each engagement begins by defining objectives.
Formation BioFormation Bio applies AI to AI-enabled clinical development platform for trial design, execution, data workflows, and faster drug development.
Chai-1Multimodal foundation model for predicting biomolecular structures and interactions across proteins, ligands, nucleic acids, and complexes